Phathom Pharmaceuticals, Inc.
Biopharmaceutical company developing novel treatments for acid-related GI diseases.
PHAT | US
Overview
Corporate Details
- ISIN(s):
- US71722W1071
- LEI:
- Country:
- United States of America
- Address:
- 100 CAMPUS DRIVE,, 7932 FLORHAM PARK
- Website:
- https://www.phathompharma.com/
- Sector:
- Manufacturing
Description
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel treatments for acid-related gastrointestinal (GI) diseases. The company's primary efforts are centered on advancing its lead product candidate, vonoprazan, a potassium-competitive acid blocker (P-CAB). This therapeutic is developed for a range of indications, including the treatment of erosive esophagitis, Helicobacter pylori (H. pylori) infection, and non-erosive reflux disease. Phathom aims to transform the treatment landscape for these conditions by addressing unmet medical needs and improving patient outcomes with innovative therapeutic options.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 13:05 |
8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer)
|
English | 58.2 KB |
Automate Your Workflow. Get a real-time feed of all Phathom Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Phathom Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Phathom Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
